press center press release

NASDAQ Changes Trade Halt Status of Vascular Biogenics Ltd.


NEW YORK, Aug. 8, 2014 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market® (Nasdaq:NDAQ) announced today that the trading halt status in Vascular Biogenics Ltd. (Nasdaq:VBLX) was changed to "additional information requested" from the company. Trading in the company's stock had been halted on August 7, 2014 at 17:11:25 Eastern Time for "news pending" at a last price of $11.15.

Trading will remain halted until Vascular Biogenics Ltd. has fully satisfied NASDAQ's request for additional information.

For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotesSM on the NASDAQ® Web site.

For more information about The NASDAQ Stock Market, visit the NASDAQ Web site at


CONTACT: NASDAQ OMX Media Contact: Josh Machiz +

In This Story


Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more